Autocrine/paracrine human growth hormone-stimulated MicroRNA 96-182-183 cluster promotes epithelial-mesenchymal transition and invasion in breast cancer W Zhang, P Qian, X Zhang, M Zhang, H Wang, M Wu, X Kong, S Tan, ... Journal of Biological Chemistry 290 (22), 13812-13829, 2015 | 111 | 2015 |
Cancer stem cell regulated phenotypic plasticity protects metastasized cancer cells from ferroptosis M Wu, X Zhang, W Zhang, YS Chiou, W Qian, X Liu, M Zhang, H Yan, S Li, ... Nature communications 13 (1), 1371, 2022 | 110 | 2022 |
NUDT21 negatively regulates PSMB2 and CXXC5 by alternative polyadenylation and contributes to hepatocellular carcinoma suppression S Tan, H Li, W Zhang, Y Shao, Y Liu, H Guan, J Wu, Y Kang, J Zhao, Q Yu, ... Oncogene 37 (35), 4887-4900, 2018 | 103 | 2018 |
Trefoil factor 3 promotes metastatic seeding and predicts poor survival outcome of patients with mammary carcinoma V Pandey, ZS Wu, M Zhang, R Li, J Zhang, T Zhu, PE Lobie Breast Cancer Research 16, 1-20, 2014 | 87 | 2014 |
Amplification of hsa-miR-191/425 locus promotes breast cancer proliferation and metastasis by targeting DICER1 X Zhang, M Wu, QY Chong, W Zhang, P Qian, H Yan, W Qian, M Zhang, ... Carcinogenesis 39 (12), 1506-1516, 2018 | 51 | 2018 |
Mn (II) mediated degradation of artemisinin based on Fe 3 O 4@ MnSiO 3-FA nanospheres for cancer therapy in vivo J Chen, W Zhang, M Zhang, Z Guo, H Wang, M He, P Xu, J Zhou, Z Liu, ... Nanoscale 7 (29), 12542-12551, 2015 | 51 | 2015 |
Human growth hormone and human prolactin function as autocrine/paracrine promoters of progression of hepatocellular carcinoma X Kong, W Wu, Y Yuan, V Pandey, Z Wu, X Lu, W Zhang, Y Chen, M Wu, ... Oncotarget 7 (20), 29465, 2016 | 46 | 2016 |
Post-transcriptional regulation of ERBB2 by miR26a/b and HuR confers resistance to tamoxifen in estrogen receptor-positive breast cancer cells S Tan, K Ding, QY Chong, J Zhao, Y Liu, Y Shao, Y Zhang, Q Yu, Z Xiong, ... Journal of Biological Chemistry 292 (33), 13551-13564, 2017 | 42 | 2017 |
Artemin is hypoxia responsive and promotes oncogenicity and increased tumor initiating capacity in hepatocellular carcinoma M Zhang, W Zhang, Z Wu, S Liu, L Sun, Y Zhong, X Zhang, X Kong, ... Oncotarget 7 (3), 3267, 2015 | 33 | 2015 |
Machine learning uncovers cell identity regulator by histone code B Xia, D Zhao, G Wang, M Zhang, J Lv, AS Tomoiaga, Y Li, X Wang, ... Nature communications 11 (1), 2696, 2020 | 32 | 2020 |
Loss of Estrogen-Regulated MIR135A1 at 3p21.1 Promotes Tamoxifen Resistance in Breast Cancer W Zhang, M Wu, QY Chong, M Zhang, X Zhang, L Hu, Y Zhong, P Qian, ... Cancer research 78 (17), 4915-4928, 2018 | 32 | 2018 |
BMI1 is directly regulated by androgen receptor to promote castration-resistance in prostate cancer S Zhu, D Zhao, C Li, Q Li, W Jiang, Q Liu, R Wang, L Fazli, Y Li, L Zhang, ... Oncogene 39 (1), 17-29, 2020 | 24 | 2020 |
Hypomethylation associated enhanced transcription of trefoil factor-3 mediates tamoxifen-stimulated oncogenicity of ER+ endometrial carcinoma cells V Pandey, M Zhang, QY Chong, M You, AR Raquib, AK Pandey, DX Liu, ... Oncotarget 8 (44), 77268, 2017 | 15 | 2017 |
Broad genic repression domains signify enhanced silencing of oncogenes D Zhao, L Zhang, M Zhang, B Xia, J Lv, X Gao, G Wang, Q Meng, Y Yi, ... Nature communications 11 (1), 5560, 2020 | 14 | 2020 |
Expression of two non-mutated genetic elements is sufficient to stimulate oncogenic transformation of human mammary epithelial cells V Pandey, M Zhang, M You, W Zhang, R Chen, W Zhang, L Ma, ZS Wu, ... Cell death & disease 9 (12), 1147, 2018 | 13 | 2018 |
CHD6 promotes broad nucleosome eviction for transcriptional activation in prostate cancer cells D Zhao, M Zhang, S Huang, Q Liu, S Zhu, Y Li, W Jiang, DL Kiss, Q Cao, ... Nucleic acids research 50 (21), 12186-12201, 2022 | 7 | 2022 |
SHON is a novel estrogen-regulated oncogene in mammary carcinoma that predicts patient response to endocrine therapy Y Jung, TMA Abdel-Fatah, SYT Chan, CC Nolan, AR Green, IO Ellis, L Li, ... Cancer research 73 (23), 6951-6962, 2013 | 7 | 2013 |
ARTEMIN promotes oncogenicity and resistance to 5-fluorouracil in colorectal carcinoma by p44/42 MAPK dependent expression of CDH2 QS Zhuang, XB Sun, QY Chong, A Banerjee, M Zhang, ZS Wu, T Zhu, ... Frontiers in Oncology 11, 712348, 2021 | 5 | 2021 |
The therapeutic potential of targeting the CHD protein family in cancer M Zhang, K Wu, W Zhang, X Lin, Q Cao, L Zhang, K Chen Pharmacology & Therapeutics, 108610, 2024 | 1 | 2024 |